These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 29544405)
1. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass. Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405 [TBL] [Abstract][Full Text] [Related]
2. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal? Gatti G; Pugliese P Cardiovasc Surg; 2002 Jun; 10(3):245-50. PubMed ID: 12044433 [TBL] [Abstract][Full Text] [Related]
3. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211 [TBL] [Abstract][Full Text] [Related]
4. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. Levin AI; Heine AM; Coetzee JF; Coetzee A J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364 [TBL] [Abstract][Full Text] [Related]
5. Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system. Scrascia G; Rotunno C; Guida P; Conte M; Amorese L; Margari V; Schinosa Lde L; Paparella D Interact Cardiovasc Thorac Surg; 2013 May; 16(5):636-42. PubMed ID: 23335652 [TBL] [Abstract][Full Text] [Related]
6. Clinical effects of different protamine doses after cardiopulmonary bypass. Svenarud P; Øvrum E Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):119-23. PubMed ID: 12079933 [TBL] [Abstract][Full Text] [Related]
7. Individualized heparin monitoring and management reduces protamine requirements in cardiac surgery on minimal invasive extracorporeal circulation; A prospective randomized study. Gkiouliava A; Argiriadou H; Antonitsis P; Goulas A; Papapostolou E; Sarridou D; Karapanagiotidis GT; Anastasiadis K Perfusion; 2024 Nov; 39(8):1595-1604. PubMed ID: 37776194 [TBL] [Abstract][Full Text] [Related]
8. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Shore-Lesserson L; Reich DL; DePerio M Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020 [TBL] [Abstract][Full Text] [Related]
9. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial. Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705 [TBL] [Abstract][Full Text] [Related]
10. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass. Miles LF; Marchiori P; Falter F Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026 [TBL] [Abstract][Full Text] [Related]
11. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery. Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152 [TBL] [Abstract][Full Text] [Related]
12. A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin. Nilsson J; Scicluna S; Malmkvist G; Pierre L; Algotsson L; Paulsson P; Bjursten H; Johnsson P Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):834-9. PubMed ID: 22914806 [TBL] [Abstract][Full Text] [Related]
13. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery. Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199 [TBL] [Abstract][Full Text] [Related]
16. Protamine titration to optimize heparin antagonization after cardiopulmonary bypass. Foubert R; Van Vaerenbergh G; Cammu G; Buys S; De Mey N; Lecomte P; Bouchez S; Rex S; Foubert L Perfusion; 2024 Sep; 39(6):1062-1069. PubMed ID: 36503295 [TBL] [Abstract][Full Text] [Related]
17. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study. Runge M; Møller CH; Steinbrüchel DA J Extra Corpor Technol; 2009 Mar; 41(1):10-4. PubMed ID: 19361026 [TBL] [Abstract][Full Text] [Related]
18. Protamine dosage based on two titrations reduces blood loss after valve replacement surgery: a prospective, double-blinded, randomized study. Guo Y; Tang J; Du L; Liu J; Liu RC; Liu X; Guo Y Can J Cardiol; 2012; 28(5):547-52. PubMed ID: 22633184 [TBL] [Abstract][Full Text] [Related]
19. Safety issues in heparin and protamine administration for extracorporeal circulation. Jobes DR J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571 [TBL] [Abstract][Full Text] [Related]
20. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial. Arsenault KA; Paikin JS; Hirsh J; Dale B; Whitlock RP; Teoh K; Young E; Ginsberg JS; Weitz JI; Eikelboom JW J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]